Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$204.13 - $302.4 $256,387 - $379,814
-1,256 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$255.51 - $362.11 $12,519 - $17,743
49 Added 4.06%
1,256 $357,000
Q4 2021

Feb 08, 2022

BUY
$351.38 - $448.68 $152,850 - $195,175
435 Added 56.35%
1,207 $455,000
Q3 2021

Nov 02, 2021

BUY
$372.64 - $458.3 $287,678 - $353,807
772 New
772 $318,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Blue Chip Partners, Inc. Portfolio

Follow Blue Chip Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Chip Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Blue Chip Partners, Inc. with notifications on news.